A sell-off in chip stocks intensified following a report that chipmakers are cutting ties with Huawei after the Trump administration's ban.Marketsread more
The S&P 500 is only about 3% from its recent record high despite a tariff panic sell-off, negative investor sentiment and stock outflows.Trading Nationread more
Ford Motor said Monday that it is laying off about 7,000 salaried workers, about 10% of that global workforce, as part of a restructuring plan designed to save the No. 2...Autosread more
President Trump stands a chance of creating a new economic world order in his China trade fight, says the chief economic advisor of Allianz.Economyread more
Most U.S. hedge funds aren't expecting another big stock market sell-off as more firms curb bets on volatility, according to Nomura.Marketsread more
People investing in some technology stocks should not expect them to go up anytime soon, warns the "Mad Money" host.Investingread more
Google has suspended business activity involving the transfer of hardware, software and key technical services with Huawei. Analysts say that could be a big blow to the...Technologyread more
Sprint and T-Mobile US on Monday will announce a series of changes to their $26 billion deal, while U.S. regulators are expected to announce agreement on the conditions...Technologyread more
Wedbush cuts its price target on Tesla shares to $230 from $275.Investingread more
The suit claims Lyft failed to disclose issues it knew about concerning its bike-sharing program and labor.Technologyread more
Robert Smith announced that he and his family would set up a grant to pay off the nearly 400 graduating seniors' student loans. The total gift is estimated at $40 million.Personal Financeread more
Goldman Sachs told investors to buy Intuitive Surgical shares because robot-assisted procedures will double in the next two years. The firm initiated coverage on the surgical robot maker with a buy rating.
Intuitive Surgical is one of the best-performing stocks in the market this year. The company's shares are up 34 percent year to date compared with the S&P 500's 7 percent return.
"With less than 4 percent of U.S. surgeries employing robotics today, we think investors should own this structural winner as the market doubles in the next few years," analyst Isaac Ro wrote in a note to clients Tuesday. "We think emerging markets are underappreciated and near-term concerns on competition are overblown given ISRG's proven outcomes/ease."
His Intuitive Surgical 12-month price target is $1,000, representing 18 percent upside from Monday's close of $850.67.
Ro predicts robot-assisted procedures will rise by 100 percent in the next two years due to increasing usage during hernia and gall bladder surgeries. He also noted that less than 3 percent of tier-three (facilities with more than 500 beds) hospitals in China have an Intuitive Surgical robot system.
"As the Tier 3 hospital market in China is the same size as the entire U.S. hospital market, we think the long-term opportunity to expand the installed base in China is significant and underappreciated," he wrote.
As a result, Ro estimates Intuitive Surgical will generate earnings per share of $23.87 in 2017 and $27.30 in 2018 compared with the Wall Street consensus of $23.60 and $27.08, respectively.
"We see new product cycles, an expanding platform, high hurdles for physician training, and significant financial resources as tail winds to ISRG's competitive position," the analyst wrote.
— CNBC's Michael Bloom contributed to this story.